梗阻性膀胱逼尿肌功能失调分子机制的研究进展

doi:10.16352/j.issn.1001-6325.2022.10.1606

基础医学与临床 ›› 2022, Vol. 42 ›› Issue (10): 1606-1610.doi: 10.16352/j.issn.1001-6325.2022.10.1606

梗阻性膀胱逼尿肌功能失调分子机制的研究进展

刘胜来^1,2, 田大伟^1,2, 吴长利^1,2*

1.天津医科大学第二医院泌尿外科/天津市泌尿外科研究所/天津市泌尿外科基础医学重点实验室, 天津 300211;
2.天津医科大学中新生态城医院泌尿肾病科, 天津 300467

收稿日期:2021-06-23 修回日期:2021-11-11 出版日期:2022-10-05 发布日期:2022-09-23
通讯作者: * wucl2003@163.com
基金资助:
天津市滨海新区卫健委科技项目(2017BWKY034); 天津市“131”创新型人才培养工程专项(滨人才[2020]7号)

Advances in molecular mechanism of bladder detrusor dysfunction

LIU Sheng-lai^1,2, TIAN Da-wei^1,2, WU Chang-li^1,2*

1. Department of Urology, the Second Hospital of Tianjin Medical University/Tianjin Key Laboratory of Basic Urology/Tianjin Urology Institute, Tianjin 300211;
2. Department of Urology, Sino-Singapore Eco-City Hospital of Tianjin Medical University, Tianjin 300467, China

Received:2021-06-23 Revised:2021-11-11 Online:2022-10-05 Published:2022-09-23
Contact: * wucl2003@163.com

摘要/Abstract

摘要： 膀胱出口梗阻 (BOO) 增加了排尿阻力,也延长了膀胱内高压的持续时间。腔内压力升高使逼尿肌受到的静水压力和机械拉伸力超出负荷时,促发了肌细胞以机械张力应激、低氧、缺血再灌注损伤 (IRI)为始的级联反应,引起细胞内代谢的改变和细胞外基质的重构。此病理损伤具有不可逆性,最终的结局是膀胱功能失代偿,出现肾衰竭等严重并发症。确切病理机制尚不完全清楚,发病机制的探索有利于疾病的早期发现,实现精准治疗。

关键词: 膀胱出口梗阻, 膀胱重构, 尿路上皮纤维化, 平滑肌细胞

Abstract: Bladder outlet obstruction (BOO) increases micturition resistance and prolongs the duration of intravesical hypertension. The intravesical pressure overloads the hydrostatic pressure and mechanical tensile force of detrusor,which triggers the cascade reaction of muscle cells starting from mechanical tension stress, hypoxia and ischemia-reperfusion injury (IRI), leading to changes in intracellular metabolism and reconstruction of extracellular matrix.The change of interstitial components is irreversible injury, and there is no effective treatment measures in the decompensation stage. At present, the exact pathogenesis is not completely clear. The study on the pathogenesis of BOO may support early detection of obstructive dysuria, which is of great significance for clinical treatment.

Key words: bladder outlet obstruction, bladder remodeling, urothelial fibrosis, smooth muscle

中图分类号:

R697

刘胜来, 田大伟, 吴长利. 梗阻性膀胱逼尿肌功能失调分子机制的研究进展[J]. 基础医学与临床, 2022, 42(10): 1606-1610.

LIU Sheng-lai, TIAN Da-wei, WU Chang-li. Advances in molecular mechanism of bladder detrusor dysfunction[J]. Basic & Clinical Medicine, 2022, 42(10): 1606-1610.

0
/ / 推荐

导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

链接本文: http://journal11.magtechjournal.com/Jwk_jcyxylc/CN/10.16352/j.issn.1001-6325.2022.10.1606

http://journal11.magtechjournal.com/Jwk_jcyxylc/CN/Y2022/V42/I10/1606

参考文献 26

[1]	Kathryn BE.The epidemiology of benign prostatic hyperplasia associated with lower urinary tract symptoms: prevalence and incident rates[J].Urol Clin North Am,2016,43:289-297.
[2]	Soum DL, Benjamin TH, Eric W, et al. Epidemiology and treatment modalities for the management of benign prostatic hyperplasia[J].Transl Androl Urol,2019,8:529-539.
[3]	Tracey AT, Anele UA, Vince RA, et al. Bladder attack: transient bladder ischemia leads to a reversible decrease in detrusor compliance[J]. Transl Androl Urol, 2019,8:703-711.
[4]	Yang JH, Li Y, Azad R, et al. Regulation of cellular stress signaling in bladder ischemia[J].Res Rep Urol,2020,12:391-402.
[5]	Tykocki NR, Monson FC. Excitability and contractility in arterioles and venules from the urinary bladder[J]. Curr Top Membr, 2020,85:301-326.
[6]	Brooks KCL, Varette K, Harvey MA, et al.A model identifying characteristics predictive of successful pelvic floor muscle training outcomes among women with stress urinary incontinence[J]. Int Urogynecol J, 2021,32:719-728.
[7]	Chao H, Deng L, Xu F, et al. MEX3C regulates lipid metabolism to promote bladder tumorigenesis through JNK pathway[J]. Onco Targets Ther,2019,12:3285-3294.
[8]	Lei L, Su J, Chen J, et al. The role of lysophosphatidic acid in the physiology and pathology of the skin[J]. Life Sci, 2019,220:194-200.
[9]	Edyta D, Karolina T, Przemysław B, et al.Crosstalk between the TGF-β and WNT signalling pathways during cardiac fibrogenesis[J].Acta Biochim Pol,2018,65:341-349.
[10]	Wiafe B, Adesida AB, Churchill T, et al. Mesenchymal stem cell therapy inhibited inflammatory and profibrotic pathways induced by partial bladder outlet obstruction and prevented high-pressure urine storage[J]. J Pediatr Urol,2019,1515:254.e1-254.e10. doi: 10.1016/jpuro.2019.03.003.
[11]	Altunkaynak CHO, Yazihan N.The pretreatment of rats with nebivolol ameliorates bladder contractile dysfunction caused by ischemia-reperfusion injury[J]. Low Urin Tract Symptoms,2021,13:183-188.
[12]	Park JM, Lee JY, Na YG, et al. Changes in apoptosis-related proteins in the urothelium of rat bladder following partial bladder outlet obstruction and subsequent relief[J]. Urol J, 2020,18:230-236.
[13]	Liang S, Wang Y, Liu Y. Dexmedetomidine alleviates lung ischemia-reperfusion injury in rats by activating PI3K/Akt pathway[J]. Eur Rev Med Pharmacol Sci,2019,23:370-377.
[14]	Radford A, Hinley J, Pilborough A,et al.Hypoxic changes to the urothelium as a bystander of end-stage bladder disease[J]. J Pediatr Urol,2019,158.e1-158.e10. doi: 10.1016/jpurol.2019.01.012.
[15]	Zhao F, Zhou L, Xu Z,et al. Hypoxia-preconditioned adipose-derived endothelial progenitor cells promote bladder augmentation[J]. Tissue Eng Part A,2020,26:78-92.
[16]	Wang N, Duan L, Ding J, et al. MicroRNA-101 protects bladder of BOO from hypoxia-induced fibrosis by attenuat-ing TGF-beta-smad2/3 signaling[J]. IUBMB Life,2019,71:235-243.
[17]	贾春松,赵彦坡,尚振华,等. RNA干扰降低膀胱TGF-β1表达能够改善脊髓损伤大鼠的膀胱功能和纤维化[J].基础医学与临床,2021, 41: 1007-1012.
[18]	Wiafe B, Adesida A, Churchill T, et al. Hypoxia increased expression of genes involved in inflammation, dedifferentiation, pro-fibrosis, and extracellular matrix remodeling of human bladder smooth muscle cells[J]. In Vitro Cell Dev Biol Anim,2017,53:58-66.
[19]	Christian H, Randy SH, Gur PK, et al. Role of meprin metalloproteinases in cytokine processing and inflammation[J].Cytokine,2019,114:18-25.
[20]	Grundy L, Caldwell A, Garcia Caraballo S, et al. Histamine induces peripheral and central hypersensitivity to bladder distension via the histamine H(1) receptor and TRPV1[J]. Am J Physiol Renal Physiol, 2020,318:F298-F314.
[21]	Mann N, Kause F, Henze EK, et al.CAKUT and autonomic dysfunction caused by acetylcholine receptor mutations[J]. Am J Hum Genet, 2019,105:1286-1293.
[22]	Erin MM, Devkumar M, Brian WS, et al. Magnetic resonance imaging and molecular characterization of a hormone-mediated murine model of prostate enlargement and bladder outlet obstruction[J].Am J Pathol,2017,187: 2378-2387.
[23]	Sidler M, Aitken KJ, Jiang JX,et al. DNA methylation reduces the yes-associated protein 1/WW domain containing transcription regulator 1 pathway and prevents pathologic remodeling during bladder obstruction by limiting expression of BDNF[J]. Am J Pathol,2018,188:2177-2194.
[24]	Chellappagounder T, Cristiano MG, Stephen AZ,et al. NF-κB and GATA-binding factor 6 repress transcription of caveolins in bladder smooth muscle hypertrophy[J].Am J Pathol, 2019,189:847-867.
[25]	Liu M, Gomez D. Smooth musclecell phenotypic diversity[J]. Arterioscler Thromb Vasc Biol, 2019,39:1715-1723.
[26]	Gabella G.Muscle cells, nerves, fibroblasts and vessels in the detrusor of the rat urinary bladder[J].J Smooth Muscle Res,2019,55:34-67.

梗阻性膀胱逼尿肌功能失调分子机制的研究进展

Advances in molecular mechanism of bladder detrusor dysfunction

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 26

相关文章 15

编辑推荐

Metrics

本文评价

[1]	谢思安, 徐俊玄, 宁婷婷, 张楠, 朱圣韬, 刘思. VAV1是动脉粥样硬化预后的潜在靶点和生物标志物[J]. 基础医学与临床, 2022, 42(7): 1092-1098.
[2]	孙秋菊, 焦晓璐, 于华惠, 李凡, 吕倩雯, 王钰, 秦彦文. 血管生成素样蛋白8促进大鼠主动脉血管平滑肌细胞表型转化[J]. 基础医学与临床, 2022, 42(5): 745-751.
[3]	商瑀家, 李玉霞, 宋佳新, 李宏霞. 钙敏感受体在动脉粥样硬化中的作用研究进展[J]. 基础医学与临床, 2020, 40(3): 395-398.
[4]	王峰甄雅楠刘晓鹏林凡刘鹏温见燕. 慢性血栓栓塞性肺动脉高压患者血管平滑肌细胞中FoxO3a和MMP2表达升高[J]. 基础医学与临床, 2019, 39(5): 652-656.
[5]	魏小栋肖永光. Notch和HES蛋白表达在大鼠静脉桥狭窄中的作用[J]. 基础医学与临床, 2014, 34(10): 1401-1404.
[6]	姜怡邓孙炜炜马长剑王菊马胜超巩慧慧梁宇. LDLR启动子区DNA甲基化调控同型半胱氨酸致平滑肌细胞增殖的作用机制[J]. 基础医学与临床, 2012, 32(3): 245-250.
[7]	李林陈晓锐宋莎莎焦玉莲马春燕鞠远荣李建峰. 过氧亚硝酸盐增强人脑血管平滑肌细胞PDCD4基因表达[J]. 基础医学与临床, 2010, 30(9): 956-960.
[8]	揭伟罗泊涛姜汉国陈锦申志华. 高糖上调大鼠主动脉平滑肌细胞骨桥蛋白表达[J]. 基础医学与临床, 2010, 30(8): 852-856.
[9]	鲁云彪陈厚早张冉郑伟李莉张庆军刘德培. SIRT1上调大鼠血管平滑肌细胞p27Kip1的表达[J]. 基础医学与临床, 2010, 30(7): 714-720.
[10]	呼海娟;韩梅;孙荣华;刘彬;温进坤. 黄芩苷抑制大鼠血管平滑肌细胞增殖和新生内膜肥厚[J]. 基础医学与临床, 2010, 30(12): 1252-1256.
[11]	王跃秀刘岩王丛刘杰王军. 瞬时感受器电位香草酸受体1参与低氧性人肺动脉平滑肌细胞系的增殖[J]. 基础医学与临床, 2010, 30(11): 1163-1166.
[12]	张丹丹徐占民宋爱丽赵全明董小黎. 兔不稳定斑块的18F-FDG PET/CT显像及其病理学检测[J]. 基础医学与临床, 2010, 30(1): 33-36.
[13]	汪长东陈鹏闫旭何光源. 露蜂房蛋白抑制大鼠支气管平滑肌细胞增殖的可能机制[J]. 基础医学与临床, 2009, 29(7): 683-687.
[14]	孙银平王省张大伟王晓冰郭勇. 血管狭窄大鼠血浆AngII与血管PDGF-B表达的变化[J]. 基础医学与临床, 2009, 29(7): 759-760.
[15]	林加日李桂林梁尚栋. 血管P2受体的功能及其与某些血管疾病的关系[J]. 基础医学与临床, 2009, 29(12): 1331-1333.